Worcester’s Hanover Theatre has something for everyone when it comes to entertainment. Mania continues its quest to bring the ...

On Oct. 13 the Richmond Register carried a column about gender social dynamics within the Richmond, Kentucky Weekly Messenger ...

Thoughtful presents she'll love (nearly) as much as you - Discover the top mum-friendly Christmas gifts of 2025 that will ...

President Bola Tinubu has extended his condolences to the Senate Minority Leader, Senator Abba Moro, following the tragic deaths of his son, Victor Moro, and grandson, Abba Moro Jr. In a Tuesday ...

Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings.

The Senate Minority Leader, Senator Abba Moro, has lost his son and grandson within 48 hours, a heartbreaking incident that has thrown the family and political associates into mourning. Moro’s son, ...

Learn all about the groundbreaking London arena show and the best way to book Abba Voyage tickets Beloved Swedish band Abba is back, and in a way you’ve never seen them before. Agnetha Fältskog, Björn ...

Co-led by NfX and Eka VC, investors include Cocoa VC, Wilbe, and Angel investors Investment will support development of whole tissue-based platform for identification of druggable targets and scaling ...

Its time to blow out your bangs and fish out your flares, its the ABBA bottomless brunch! Playing the best hits from the biggest group of all time, ABBA! Its time to Voulez-Vouz your way down to this ...

Regeneron has given up on a CAR-T candidate acquired from 2seventy bio last year, before it entered the second part of a phase 1/2 lymphoma study. The dual-targeting CAR-T, dubbed bbT369, was being ...

Bio-Reference Laboratories, Inc. provides clinical laboratory testing, information and related services to physician offices, clinics, hospitals, employers and governmental units. It offers a ...

Nuvation Bio (NUVB) announced enrollment of the first patient into part 2 of G203, a global, randomized study evaluating the efficacy and safety of safusidenib versus placebo for the maintenance ...